The relationship of the immune response mediator genes' polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis

Background/aim: The aim of the study was to analyze the relationship of the immune response mediator genes' polymorphic loci TNFA rs1800629, LTA rs909253, IL1B rs16944, IL2-IL21 rs6822844, IL2RA rs2104286, IL6 rs1800795, IL10 rs1800872, MIF rs755622, CTLA4 rs3087243, NFKB1 rs28362491, PTPN22 rs2476601, PADI4 rs2240336 variants with the methotrexate efficacy in juvenile idiopathic arthritis JIA . Materials and methods: The study included 274 JIA patients from the Republic of Bashkortostan, Russia. Achieving the American College of Rheumatology Pediatric 30 ACR Pedi 30 response was regarded as the presence of the response to methotrexate otherwise, as the absence , while achieving clinical remission on medication Wallace et al., 2011 - as the sufficient response otherwise, as the insufficient . Genotyping was conducted by the real-time polymerase chain reaction. Results: Associations with an altered risk of the nonresponse to methotrexate in JIA were observed for the alleles/genotypes of the loci IL10 rs1800872 in girls and NFKB1 rs28362491 in girls ; with an altered risk of the insufficient response to methotrexate in JIA - for the alleles/genotypes of the loci IL1B rs16944 in boys , CTLA4 rs3087243 in boys , NFKB1 rs28362491 in girls and the haplotype TNFA rs1800629*A - LTA rs909253*G in girls . Conclusion: As a result of the study, the relationship of the alleles/genotypes of the IL1B rs16944, IL10 rs1800872, CTLA4 rs3087243, NFKB1 rs28362491 polymorphic loci and the TNFA rs1800629*A - LTA rs909253*G haplotype with the methotrexate efficacy in JIA was established taking into account the differences by sex .

___

  • 1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of Rheumatology 2004; 31 (2): 390-392.
  • 2. Kim KH, Kim DS. Juvenile idiopathic arthritis: DIAGNOSIS ANd differential diagnosis. Korean Journal of Pediatrics 2010; 53 (11): 931-935. doi: 10.3345/kjp.2010.53.11.931
  • 3. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Medical Journal 2017; 34 (2): 90-101. doi: 10.4274/balkanmedj.2017.0111
  • 4. van Dijkhuizen EH, Wulffraat NM. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. Pediatric Rheumatology 2014; 12: 51. doi: 10.1186/1546-0096-12-51
  • 5. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O’Neil KM et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis & Rheumatism 2012; 64 (6): 2012-2021. doi: 10.1002/art.34343
  • 6. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research 2011; 63 (4): 465-482. doi: 10.1002/acr.20460
  • 7. Albarouni M, Becker I, Horneff G. Predictors of response to methotrexate in juvenile idiopathic arthritis. Pediatric Rheumatology 2014; 12: 35. doi: 10.1186/1546-0096-12-35
  • 8. Roszkiewicz J, Smolewska E. In the pursuit of methotrexate treatment response biomarker in juvenile idiopathic arthritisare we getting closer to personalised medicine? Current Rheumatology Reports 2017; 19 (4): 19. doi: 10.1007/s11926- 017-0646-8
  • 9. Pastore S, Stocco G, Favretto D, De Iudicibus S, Taddio A et al. Genetic determinants for methotrexate response in juvenile idiopathic arthritis. Frontiers in Pharmacology 2015; 6: 52. doi: 10.3389/fphar.2015.00052
  • 10. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, GawronskaSzklarz B. Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. International Immunopharmacology 2006; 6 (3): 351-357. doi: 10.1016/j. intimp.2005.08.019
  • 11. Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B et al. Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications. World Journal of Orthopedics 2014; 5 (4): 516-536. doi: 10.5312/wjo.v5.i4.516
  • 12. Bedoui Y, Guillot X, Sélambarom J, Guiraud P, Giry C et al. Methotrexate an old drug with new tricks. International Journal of Molecular Sciences 2019; 20 (20): E5023. doi: 10.3390/ijms20205023
  • 13. Cribbs AP, Kennedy A, Penn H, Amjadi P, Green P et al. methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis & Rheumatology 2015; 67 (5): 1182-1192. doi: 10.1002/art.39031
  • 14. Schmeling H, Horneff G, Benseler SM, Fritzler MJ. Pharmacogenetics: can genes determine treatment efficacy and safety in JIA? Nature Reviews Rheumatology 2014; 10 (11): 682-690. doi: 10.1038/nrrheum.2014.140
  • 15. Cobb J, Cule E, Moncrieffe H, Hinks A, Ursu S et al. Genomewide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. The Pharmacogenomics Journal 2014; 14 (4): 356-364. doi: 10.1038/tpj.2014.3
  • 16. Moncrieffe H, Hinks A, Ursu S, Kassoumeri L, Etheridge A et al. Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype. Pharmacogenetics and Genomics 2010; 20 (11): 665-676. doi: 10.1097/FPC.0b013e32833f2cd0
  • 17. Hersh AO, Prahalad S. Immunogenetics of juvenile idiopathic arthritis: A comprehensive review. Journal of Autoimmunity 2015; 64: 113-124. doi: 10.1016/j.jaut.2015.08.002
  • 18. Hisa K, Yanagimachi MD, Naruto T, Miyamae T, Kikuchi M et al. PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis. PLoS ONE 2017; 12 (2): e0171961. doi: 10.1371/journal.pone.0171961
  • 19. Grom AA, Murray KJ, Luyrink L, Emery H, Passo MH et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis & Rheumatism 1996; 39 (10): 1703-1710. doi: 10.1002/art.1780391013
  • 20. Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care & Research 2011; 63 (7): 929-936. doi: 10.1002/acr.20497
  • 21. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT et al. Preliminary definition of improvement in juvenile arthritis. Arthritis & Rheumatism 1997; 40 (7): 1202-1209. doi: 10.1002/ art.1780400703
  • 22. Wallace CA, Ruperto N, Giannini EH. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. The Journal of Rheumatology 2004; 31 (11): 2290- 2294.
  • 23. Mathew CGP. The isolation of high molecular weight eukaryotic DNA. In: Walker JM (editor). Methods in Molecular Biology, Volume 2: Nucleic Acids. Clifton, NJ, USA: Humana Press; 1984. pp. 31-34. doi: 10.1385/0-89603-064-4:31
  • 24. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005; 21 (9): 2128-2129. doi: 10.1093/bioinformatics/bti282
  • 25. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22 (15): 1928-1929. doi: 10.1093/bioinformatics/btl268
  • 26. McDonald JH. Handbook of Biological Statistics. 3rd ed. Baltimore, MD, USA: Sparky House Publishing; 2014
  • 27. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment. New York, NY, USA: John Wiley & Sons; 1993.
  • 28. Fagerland MW, Lydersen S, Laake P. Recommended confidence intervals for two independent binomial proportions. Statistical Methods in Medical Research 2015; 24 (2): 224-254. doi: 10.1177/0962280211415469
  • 29. Pociot F, Mølvig J, Wogensen L, Worsaae H, Dalbøge H et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scandinavian Journal of Immunology 1991; 33 (1): 37-49. doi: 10.1111/j.1365-3083.1991.tb02490.x
  • 30. Wang S, Cowley LA, Liu XS. Sex differences in cancer immunotherapy efficacy, biomarkers, and therapeutic strategy. Molecules 2019; 24 (18): pii: E3214. doi: 10.3390/ molecules24183214
  • 31. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH et al. Single nucleotide polymorphisms in the human interleukin1B gene affect transcription according to haplotype context. Human Molecular Genetics 2006; 15 (4): 519-529
  • 32. Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG et al. Effects of haplotypes in the interleukin 1β promoter on lipopolysaccharide-induced interleukin 1β expression. Shock 2006; 26 (1): 25-30. doi: 10.1097/01.shk.0000223125.56888.c7
  • 33. Nazarova LS, Danilko KV, Malievsky VA, Bakirov AB, Viktorova TV. The immune response mediator genes polymorphic variants as predictors of the etanercept efficacy in juvenile idiopathic arthritis. Russian Open Medical Journal 2018; 7 (2): e0204. doi: 10.15275/rusomj.2018.0204
  • 34. Rowshanravan B, Halliday N, Sansom DM. CTLA-4: a moving target in immunotherapy. Blood 2018; 131 (1): 58-67. doi: 10.1182/blood-2017-06-741033
  • 35. Kasela S, Kisand K, Tserel L, Kaleviste E, Remm A et al. Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells. PLoS Genetics 2017; 13 (3): e1006643. doi: 10.1371/journal. pgen.1006643
  • 36. Pereira SG, Oakley F. Nuclear factor-κB1: Regulation and function. The International Journal of Biochemistry & Cell Biology 2008; 40 (8): 1425-1430. doi: 10.1016/j. biocel.2007.05.004
  • 37. Yang YN, Zhang JY, Ma YT, Xie X, Li XM et al. -94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China. Genetic Testing and Molecular Biomarkers 2014; 18 (6): 430-438. doi: 10.1089/gtmb.2013.0431
  • 38. Stegger JG, Schmidt EB, Berentzen TL, Tjønneland A, Vogel U et al. Interaction between obesity and the NFKB1 - 94ins/ delATTG Promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts. PLoS ONE 2013; 8 (5): e63004. doi: 10.1371/journal. pone.0063004
  • 39. Mangoni AA, Zinellu A, Sotgia S, Carru C, Piga M et al. Protective effects of methotrexate against proatherosclerotic cytokines: a review of the evidence. Mediators of Inflammation 2017; 2017: 9632846. doi: 10.1155/2017/9632846
  • 40. Ma Y, Li L, Shao Y, Bai X, Bai T et al. Methotrexate improves perivascular adipose tissue/endothelial dysfunction via activation of AMPK/eNOS pathway. Molecular Medicine Reports 2017; 15 (4): 2353-2359. doi: 10.3892/mmr.2017.6225
  • 41. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human Molecular Genetics 2004; 13 (1): 35-45. doi: 10.1093/hmg/ ddh008
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015

Mariann RUTKA, Renata BOR, Tamas MOLNAR, Klaudia FARKAS, Daniella PIGNICZKI, Anna FABIAN, Mark GYŐRFFY, Anita BALINT, Agnes MILASSIN, Ferenc NAGY, Zoltan SZEPES, Monika SZÜCS, Laszlo TISZLAVICZ

Baicalein Nanofiber Scaffold Containing Hyaluronic Acid and Polyvinyl Alcohol: Preparation and Evaluation

Kamel BACHIMAM, Ezgi EMUL, Necdet SAGLAM, Feza KORKUSUZ

Erman AKKUŞ, Çiğdem FİDAN, Gülşah DEMİRCİ, Ali Aytuğ KUŞTAŞ, Meltem YÜKSEL

The needle electromyography findings in the neurophysiological classification of ulnar neuropathy at the elbow

Halit FİDANCI, İlker ÖZTÜRK, Ahmet Candan KÖYLÜOĞLU, Mehmet YILDIZ, Şencan BUTURAK, Zülfikar ARLIER

İlknur Suidiye YORULMAZ, Yavuz DEMİRARAN, Onur ÖZLÜ, Burhan DOST

Ertuğrul Emre GÜNTÜRK, Oğuzhan BARAN, Hasan AKKAYA, Özcan ÖRSÇELİK

Pelin ÇELİK, İclal Ayrancı SUCAKLI, Halil İbrahim YAKUT

The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma

Cüneyd ANIL, Nazlı GÜLSOY KIRNAP, Özlem TURHAN İYİDİR, Yusuf BOZKUŞ, Şerife Mehlika IŞILDAK, Sevde Nur FIRAT, Canan DEMİR, Aslı NAR, Neslihan BAŞÇIL TÜTÜNCÜ

Which Bayley-III cut-off values should be used in different developmental levels?

Halil İbrahim YAKUT, Pelin ÇELİK, İclal AYRANCI SUCAKLI

Correlation between the Glasgow-Blatchford score, shock index, and Forrest classification in patients with peptic ulcer bleeding

Hong YANG, Chen PAN, Qi LIU, Yan WANG, Zhe LIU, Jingjing LEI, Xian CAO